Shona Davies and Sean Nicholson: How Do You Define “Engagement?”
In this 3-minute audio snippet, Shona L. Davies, Communications & Programme Leader, Univadis, and Sean Nicholson, Senior Director, Social Media, Intouch Solutions, define what they mean by social media
Tom Stossel: Debunking the “Conflict-of-Interest Narrative”
In this 5-minute audio snippet, Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, talks about what he calls the 'Conflict-of-Interest Narrative' or Myth, which is the subject of his new book, PharmaPhobia.
Peter Houston: Could Pharma Use Tumblr and Survive?
In this 3-minute audio snippet, Peter Houston, founder of Flipping Pages Media Ltd, discusses the pros and cons of Tumblr and whether it is possible for pharma marketers to get involved with Tumblr. Is it too Early?
Jessica Federer: Empower Pharma Employees to Advance Digitalization in Your Organization
In this 1-minute audio snippet, Jessica Federer, Head of Digital Development at Bayer, talks about how Bayer employees its employees to advance the digitalization of the organization.
Pharmaguy™’s Twitter Stream – Q2 2009
Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Preeti Pinto: How Marketers & Regulatory People Can Just Get Along
In this 3-minute audio snippet, Preeti Pinto, a regulatory consultant and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca, talks about how regulatory-savvy pharma marketers are in a better position to challenge their regulatory colleagues when they say 'No.'
The Coming Disruptive Digital Transformation of Pharma Marketing
Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities.
The Annual Pharmaguy™ Pioneer Award
Rather than recognizing specific campaigns, the Pharmaguy™ Pioneer Award gives kudos to a pharmaceutical executive or team who has 'pioneered' in the use of social media or mobile for marketing, research, patient support, or corporate communications purposes.
The Misleading Marketing of “Low-T” Drugs
A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut.
Todd D. Clark: What Can Pharma Do to Avoid the Slow-Growth Trap?
In this 3-minute audio snippet, Todd D. Clark, President of Value of Insight Consulting and the author of pharmahandbook and generichandbook, discusses a few ideas on how the pharmaceutical industry can avoid the slow-growth trap in the U.S. market.
